Polymyositis and dermatomyositis risk factors: Difference between revisions
Jump to navigation
Jump to search
Line 16: | Line 16: | ||
*** Human T-cell lymphotropic virus (HTLV-1) | *** Human T-cell lymphotropic virus (HTLV-1) | ||
*** Human immunodeficiency virus (HIV) | *** Human immunodeficiency virus (HIV) | ||
**Malignancy | *** Epstein-Barr virus (EBV) | ||
*** Adenovirus | |||
*** Influenza | |||
**Malignancy such as: | |||
*** Ovarian | |||
*** Lung | |||
*** Gastric | |||
*** Colorectal | |||
*** Pancreatic | |||
*** Non-Hodgkin’s lymphoma | |||
**Drugs such as: | **Drugs such as: | ||
***Statins | ***Statins |
Revision as of 15:17, 5 April 2018
Polymyositis and dermatomyositis Microchapters |
Differentiating Polymyositis and dermatomyositis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Polymyositis and dermatomyositis risk factors On the Web |
American Roentgen Ray Society Images of Polymyositis and dermatomyositis risk factors |
Risk calculators and risk factors for Polymyositis and dermatomyositis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
Risk Factors
- Common risk factors in the development of polymyositis and dermatomyositis include .[1]
Common Risk Factors
- Common risk factors in the development of polymyositis and dermatomyositis include:
- Viral infections such as:
- Coxsackie B virus
- Parvovirus
- Enterovirus
- Human T-cell lymphotropic virus (HTLV-1)
- Human immunodeficiency virus (HIV)
- Epstein-Barr virus (EBV)
- Adenovirus
- Influenza
- Malignancy such as:
- Viral infections such as:
- Ovarian
- Lung
- Gastric
- Colorectal
- Pancreatic
- Non-Hodgkin’s lymphoma
- Drugs such as:
- Statins
- Drugs such as:
Less Common Risk Factors
- Less common risk factors in the development of polymyositis and dermatomyositis include: